Latest News and Press Releases

MINNEAPOLIS, MINNESOTA--(Marketwired - May 1, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the U.S. Patent...

MINNEAPOLIS, MINNESOTA--(Marketwired - April 25, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) is pleased to announce the addition of Dr. Nancy Chang...

MINNEAPOLIS, MINNESOTA--(Marketwired - April 18, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), a biopharmaceutical company focused on the development...

MINNEAPOLIS, MINNESOTA--(Marketwired - March 20, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the European Patent Office has...

MINNEAPOLIS, MINNESOTA--(Marketwired - March 17, 2017) - DiaMedica Therapeutics Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announces that the Board of Directors has granted...

MINNEAPOLIS, MINNESOTA--(Marketwired - March 13, 2017) - DM199 produced a superior drug profile Identified optional dose of DM199 subcutaneous...

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 23, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today it will change its name to DiaMedica Therapeutics...

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 20, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF), a clinical stage biopharmaceutical company developing treatments for...

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 7, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today it has engaged Outreach 99 LLC ("Outreach") to assist...

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 1, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) today announced the sale and transfer of its DM-71 product and related...